Medical Excellence Capital raises $145m for debut fund
The fund will invest in cell therapy, gene therapy, AI/ML applied to drug discovery, synthetic biology, and regenerative medicine.
The fund will invest in cell therapy, gene therapy, AI/ML applied to drug discovery, synthetic biology, and regenerative medicine.
Copyright PEI Media
Not for publication, email or dissemination